We believe these findings contribute to a deeper understanding of the molecular mechanisms underlying bone pathology associated with cancer metastasis and warrant further investigation into therapeutic strategies targeting the Hif1α/Hmox1 axis. This evidence concerns the gene HIF1A and cancer.